Letter | Published:

Lifespan extension induced by AMPK and calcineurin is mediated by CRTC-1 and CREB

Nature volume 470, pages 404408 (17 February 2011) | Download Citation


Activating AMPK or inactivating calcineurin slows ageing in Caenorhabditis elegans1,2 and both have been implicated as therapeutic targets for age-related pathology in mammals3,4,5. However, the direct targets that mediate their effects on longevity remain unclear. In mammals, CREB-regulated transcriptional coactivators (CRTCs)6 are a family of cofactors involved in diverse physiological processes including energy homeostasis7,8,9, cancer10 and endoplasmic reticulum stress11. Here we show that both AMPK and calcineurin modulate longevity exclusively through post-translational modification of CRTC-1, the sole C. elegans CRTC. We demonstrate that CRTC-1 is a direct AMPK target, and interacts with the CREB homologue-1 (CRH-1) transcription factor in vivo. The pro-longevity effects of activating AMPK or deactivating calcineurin decrease CRTC-1 and CRH-1 activity and induce transcriptional responses similar to those of CRH-1 null worms. Downregulation of crtc-1 increases lifespan in a crh-1-dependent manner and directly reducing crh-1 expression increases longevity, substantiating a role for CRTCs and CREB in ageing. Together, these findings indicate a novel role for CRTCs and CREB in determining lifespan downstream of AMPK and calcineurin, and illustrate the molecular mechanisms by which an evolutionarily conserved pathway responds to low energy to increase longevity.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


Primary accessions

Gene Expression Omnibus

Data deposits

Data have been deposited at GEO under accession number GSE25513.


  1. 1.

    , , , & The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans. Genes Dev. 18, 3004–3009 (2004)

  2. 2.

    et al. Quantitative mass spectrometry identifies insulin signaling targets in C. elegans. Science 317, 660–663 (2007)

  3. 3.

    & AMPK in health and disease. Physiol. Rev. 89, 1025–1078 (2009)

  4. 4.

    & Neuronal calcium signaling, mitochondrial dysfunction, and Alzheimer’s disease. J. Alzheimers Dis. 20 (suppl. 2). 487–498 (2010)

  5. 5.

    & The LKB1–AMPK pathway: metabolism and growth control in tumour suppression. Nature Rev. Cancer 9, 563–575 (2009)

  6. 6.

    et al. TORCs: transducers of regulated CREB activity. Mol. Cell 12, 413–423 (2003)

  7. 7.

    et al. A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Nature 456, 269–273 (2008)

  8. 8.

    et al. The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell 119, 61–74 (2004)

  9. 9.

    et al. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437, 1109–1111 (2005)

  10. 10.

    et al. Enhanced activity of the CREB co-activator Crtc1 in LKB1 null lung cancer. Oncogene 29, 1672–1680 (2010)

  11. 11.

    , , & The CREB coactivator CRTC2 links hepatic ER stress and fasting gluconeogenesis. Nature 460, 534–537 (2009)

  12. 12.

    , , , & Functional domains of the α1 catalytic subunit of the AMP-activated protein kinase. J. Biol. Chem. 273, 35347–35354 (1998)

  13. 13.

    et al. The vanilloid receptor TRPV1 is activated and sensitized by local anesthetics in rodent sensory neurons. J. Clin. Invest. 118, 763–776 (2008)

  14. 14.

    & Expression patterns and transcript processing of ftt-1 and ftt-2, two C. elegans 14-3-3 homologues. J. Mol. Biol. 268, 619–630 (1997)

  15. 15.

    , , , & Recognition of an intra-chain tandem 14-3-3 binding site within PKCε. EMBO Rep. 10, 983–989 (2009)

  16. 16.

    et al. Bioinformatic and experimental survey of 14-3-3-binding sites. Biochem. J. 427, 69–78 (2010)

  17. 17.

    et al. A CaMK cascade activates CRE-mediated transcription in neurons of Caenorhabditis elegans. EMBO Rep. 3, 962–966 (2002)

  18. 18.

    & Transcriptional regulation by the phosphorylation-dependent factor CREB. Nature Rev. Mol. Cell Biol. 2, 599–609 (2001)

  19. 19.

    , , , & Targeting CREB for cancer therapy: friend or foe. Curr. Cancer Drug Targets 10, 384–391 (2010)

  20. 20.

    et al. A survival pathway for Caenorhabditis elegans with a blocked unfolded protein response. J. Cell Biol. 158, 639–646 (2002)

  21. 21.

    , , , & Unfolded protein response genes regulated by CED-1 are required for Caenorhabditis elegans innate immunity. Dev. Cell 15, 87–97 (2008)

  22. 22.

    , , & A role for SIR-2.1 regulation of ER stress response genes in determining C. elegans life span. Dev. Cell 9, 605–615 (2005)

  23. 23.

    et al. An AMPK-FOXO pathway mediates longevity induced by a novel method of dietary restriction in C. elegans. Curr. Biol. 17, 1646–1656 (2007)

  24. 25.

    et al. Glucose controls CREB activity in islet cells via regulated phosphorylation of TORC2. Proc. Natl Acad. Sci. USA 105, 10161–10166 (2008)

  25. 26.

    et al. Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding protein. Cell Metab. 10, 499–506 (2009)

  26. 27.

    et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310, 1642–1646 (2005)

  27. 28.

    et al. Adipocyte CREB promotes insulin resistance in obesity. Cell Metab. 9, 277–286 (2009)

  28. 29.

    , , , & A role for the CREB co-activator CRTC2 in the hypothalamic mechanisms linking glucose sensing with gene regulation. EMBO Rep. 10, 1175–1181 (2009)

  29. 30.

    elegans: A Practical Approach (ed. Hames. B. D.) (Oxford Univ. Press, 1999)

  30. 31.

    et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806–811 (1998)

  31. 32.

    A simple yet effective method to manipulate C. elegans in liquid. Worm Breed. Gaz. 18, 33 (2009)

  32. 33.

    et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, R80 (2004)

  33. 34.

    Affymetrix. GeneChip Expression Analysis〉 (Affymetrix, 2004)

  34. 35.

    , , , & A model-based background adjustment for oligonucleotide expression arrays. J. Am. Stat. Assoc. 99, 909–917 (2004)

  35. 36.

    Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Gen. Mol. Biol. 3, article 3. (2004)

  36. 37.

    & Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289–300 (1995)

  37. 38.

    et al. MATCH: a tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Res. 31, 3576–3579 (2003)

  38. 39.

    et al. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res. 34, D108–D110 (2006)

  39. 40.

    & Different binding specificities and transactivation of variant CRE’s by CREB complexes. Nucleic Acids Res. 22, 1463–1469 (1994)

  40. 41.

    Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. J. Mol. Biol. 212, 563–578 (1990)

Download references


W.M. is funded by the George E. Hewitt Foundation for Medical Research, the American Federation for Aging Research and the Glenn Foundation for Medical Research. R.J.S. is funded by National Institutes of Health (NIH) R01 DK080425 and P01 CA120964. A.P.C.R. and G.M. are funded by NIH R01 HG004164, AG031097 and CA14195. A.D. is supported by NIH R01 DK070696 and AG027463. We thank the Caenorhabditis Genetics Center, the National Bioresource Project for the Nematode and Mark Alkema for providing worm strains. We are grateful to M. Raices and M. D’Angelo for critical analysis of the manuscript, DAPI images and the NUP-160::GFP construct. We also thank members of the A.D. laboratory and M. Hansen for comments on the manuscript and discussion and K. Butler for technical assistance in the early stages of this project.

Author information


  1. The Salk Institute for Biological Studies, La Jolla, California 92037, USA

    • William Mair
    • , Ianessa Morantte
    • , Ana P. C. Rodrigues
    • , Gerard Manning
    • , Marc Montminy
    • , Reuben J. Shaw
    •  & Andrew Dillin
  2. Howard Hughes Medical Institute, The Salk Institute for Biological Studies, La Jolla, California 92037, USA

    • William Mair
    • , Ianessa Morantte
    • , Reuben J. Shaw
    •  & Andrew Dillin
  3. The Glenn Foundation for Medical Research, The Salk Institute for Biological Studies, La Jolla, California 92037, USA

    • William Mair
    • , Ianessa Morantte
    • , Marc Montminy
    • , Reuben J. Shaw
    •  & Andrew Dillin
  4. Razavi Newman Center for Bioinformatics, The Salk Institute for Biological Studies, La Jolla, California 92037, USA

    • Ana P. C. Rodrigues
    •  & Gerard Manning


  1. Search for William Mair in:

  2. Search for Ianessa Morantte in:

  3. Search for Ana P. C. Rodrigues in:

  4. Search for Gerard Manning in:

  5. Search for Marc Montminy in:

  6. Search for Reuben J. Shaw in:

  7. Search for Andrew Dillin in:


W.M., I.M., M.M., R.J.S. and A.D. designed the experiments. W.M. and I.M. performed the experiments. A.P.C.R analysed the microarray data and performed the promoter analysis and W.M. analysed and performed statistical analysis on all other data. The manuscript was written by W.M. and edited by I.M., A.P.C.R., G.M., R.J.S. and A.D. All authors discussed the results and commented on the manuscript.

Competing interests

The authors declare no competing financial interests.

Corresponding authors

Correspondence to Reuben J. Shaw or Andrew Dillin.

Supplementary information

PDF files

  1. 1.

    Supplementary Information

    The file contains Supplementary Figures 1-15 with legends and Supplementary Tables 3 and 4 (see Separate files for Supplementary Tables 1, 2 and 5).

  2. 2.

    Supplementary Table 1

    This table displays normalized expression measurements for all probesets.

Excel files

  1. 1.

    Supplementary Table 2

    This table displays differentially expressed genes in each of the three mutants relative to wild-type. Each row correponds to a probeset, so a gene may appear in multiple rows. Also, reported are GO functional categories associated with each gene and CRE and TATA motifs identified upstream of each gene, the notation used follows the key: Hit Score | Palindromic | Hit Position | Hit Location in Genome | Distance to TSS | Conservation in other Caernohabditis.

  2. 2.

    Supplementary Table 5

    This table displays survival data and statistics for life span experiments.

About this article

Publication history






Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.